STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G] SHOULDER INNOVATIONS, INC. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

Shoulder Innovations, Inc. received a Schedule 13G from cultivate(MD) Holdings, LLC and affiliated individuals disclosing beneficial ownership of 1,363,394 shares of common stock, representing 6.7% of the class as of 09/30/2025.

The filing attributes the shares to four investment vehicles: CMD I (185,623 shares), CMD II (309,948), Genesis Investment Holdings (592,585), and CMD Accelerator (275,238). cultivate(MD) Holdings is the general partner or manager of these entities and is described as having voting and dispositive power over their holdings. Directors David Lawrence Blue, Matthew Fraser Ahearn, Robert Joseph Ball, and managing director R. Sean Churchill are listed as Reporting Persons and disclaim beneficial ownership except to the extent of any pecuniary interest.

Positive
  • None.
Negative
  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



cultivate(MD) Holdings, LLC
Signature:/s/ R. Sean Churchill
Name/Title:Managing Director
Date:11/12/2025
Blue David Lawrence
Signature:/s/ David Lawrence Blue
Name/Title:Self
Date:11/12/2025
Ahearn Matthew Fraser
Signature:/s/ Matthew Fraser Ahearn
Name/Title:Self
Date:11/12/2025
Ball Robert Joseph
Signature:/s/ Robert Joseph Ball
Name/Title:Self
Date:11/12/2025
Churchill R. Sean
Signature:/s/ R. Sean Churchill
Name/Title:Self
Date:11/12/2025
Exhibit Information

Exhibit 99.1 - Joint Filing Agreement, dated November 12, 2025, by and among the Reporting Persons (filed herewith).

FAQ

What did the Schedule 13G for SI disclose?

It reported beneficial ownership of 1,363,394 Shoulder Innovations common shares, equal to 6.7% of the class as of 09/30/2025.

Who are the Reporting Persons in SI’s Schedule 13G?

The Reporting Persons are cultivate(MD) Holdings, LLC, David Lawrence Blue, Matthew Fraser Ahearn, Robert Joseph Ball, and R. Sean Churchill.

How are the 1,363,394 SI shares held?

Through CMD I (185,623), CMD II (309,948), Genesis Investment Holdings (592,585), and CMD Accelerator (275,238).

What percentage of SI’s class is owned?

The filing states 6.7% of the outstanding common stock.

What role does cultivate(MD) Holdings play?

It is the general partner or manager of the listed investment entities and is described as having voting and dispositive power over their shares.

Do the individual Reporting Persons claim full beneficial ownership?

They disclaim beneficial ownership except to the extent of any pecuniary interest.

What is the event date tied to this ownership for SI?

The Schedule 13G lists the event date as 09/30/2025.
Shoulder Innovations, Inc.

NYSE:SI

SI Rankings

SI Latest News

SI Latest SEC Filings

SI Stock Data

224.16M
18.41M
Commercial Banking
Surgical & Medical Instruments & Apparatus
US
HOLLAND